Peptide T acetate
Need Assistance?
  • US & Canada:
    +
  • UK: +

Peptide T acetate

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Peptide T acetate is an HIV entry inhibitor from the V2 region of HIV-1 gp120 that acts by blocking chemokine-5 receptors (CCR5), currently under clinical trials for the treatment of HIV-related neurological and constitutional symptoms.

Category
Peptide Inhibitors
Catalog number
BAT-016374
Molecular Formula
C35H55N9O16.C2H4O2
Molecular Weight
917.91
Peptide T acetate
IUPAC Name
acetic acid;(2S,3R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S,3R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoic acid
Synonyms
H-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-OH.CH3CO2H; L-alanyl-L-seryl-L-threonyl-L-threonyl-L-threonyl-L-asparagyl-L-tyrosyl-L-threonine
Related CAS
106362-32-7 (free base) 1610056-01-3 (TFA salt)
Purity
≥95%
Sequence
ASTTTNYT.CH3CO2H
Storage
Store at -20°C
Solubility
Soluble in Water
InChI
InChI=1S/C35H55N9O16.C2H4O2/c1-13(36)28(52)40-22(12-45)31(55)41-25(15(3)47)33(57)43-26(16(4)48)34(58)42-24(14(2)46)32(56)39-21(11-23(37)51)29(53)38-20(10-18-6-8-19(50)9-7-18)30(54)44-27(17(5)49)35(59)60;1-2(3)4/h6-9,13-17,20-22,24-27,45-50H,10-12,36H2,1-5H3,(H2,37,51)(H,38,53)(H,39,56)(H,40,52)(H,41,55)(H,42,58)(H,43,57)(H,44,54)(H,59,60);1H3,(H,3,4)/t13-,14+,15+,16+,17+,20-,21-,22-,24-,25-,26-,27-;/m0./s1
InChI Key
OSPMAZUQYNYXHA-ZBMRRKLOSA-N
Canonical SMILES
CC(C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CO)NC(=O)C(C)N)O.CC(=O)O
Online Inquiry
Verification code
Inquiry Basket